Published: 16 February, 2016

Report Description

Table of Contents

Customization Options

Lateral epicondylitis is also commonly known as tennis elbow and is essentially the degeneration of the tendons attachment to the bone. The function of the tendon is to anchor the muscle to the bone and weakening of this can be quite painful. Lifting and gripping things becomes extremely painful in lateral epicondylitis. There are several reasons that result in the swelling of the elbow tendons and associated pain in the elbow joint. One of them includes the repetitive motion of swinging the forearm and elbow. Tennis players, swimmers, basketball players, golfers are some of people who tend to develop this condition. There are also certain professions such as plumbing, carpenters, and other heavy-duty professions that have witnessed a rise in tennis elbow. This is driving the growth of the lateral epicondylitis treatment market. The repeated use of the wrist by extending it against resistance is what basically causes this condition. In some cases, inappropriate use of weights in fitness centers can also cause lateral epicondylitis. Also, the geriatric population comprising adults over the age of 60 are also more prone to develop this condition owing to weakening of tendons. These factors are expected to further augment the growth of the lateral epicondylitis market. Some of the drugs currently under trials include botulinum toxin, topical nitrates and hyaluronate sodium.

One major hurdle that this market encounters is the slow development and commercialization of advanced therapies.

The market can be split into surgical and non-surgical lateral epicondylitis treatment methods and the non-surgical methods account for a larger share of the market.

The Lateral Epicondylitis Treatment market can be segmented on the basis of treatment as:

Surgical

Extracorporeal Shock Wave Therapy

Braces

Medications and Physical therapies

Others

North America and Europe hold the first and second positions respectively in terms of share of the overall lateral epicondylitis market. This can be attributed to the significantly larger geriatric population present in these regions. Higher awareness coupled with larger number of sports being played also adds to the growth of the market in those regions.

The market has been segmented based on the following geographies:

North America

South America

APAC

Europe

Middle East

Africa

Following are just a few of the companies that are operating in the Lateral Epicondylitis Treatment market:

Chugai Pharmaceutical

Kasiak Research

Moecular Phramacology Limited

Seikagaku Corporation

Teikoku Pharma

1. Lateral Epicondylitis Treatment Market Overview

2. Executive Summary

3. Lateral Epicondylitis Treatment Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End User Profiling

3.2.3. Top 5 Financials Analysis

4. Lateral Epicondylitis Treatment Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Lateral Epicondylitis Treatment Market

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New Entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. Lateral Epicondylitis Treatment Market  Strategic Analysis

5.1. Value Chain Analysis

5.2. Pricing Analysis

5.3. Opportunities Analysis

5.4. Product/Market Life Cycle Analysis

5.5. Suppliers and Distributors

6. Lateral Epicondylitis Treatment Market By Type of Treatment

6.1. Surgical

6.2. Extracorporeal Shock Wave Therapy

6.3. Braces

6.4. Medications

6.5. Physical therapies

6.6. Others

7. Lateral Epicondylitis Treatment Market By Geography

7.1. Introduction

7.2. Global Study

7.3. Americas

7.3.1. North America

7.3.2. Brazil

7.3.3. Argentina

7.3.4. Others

7.4. Europe

7.4.1. U.K.

7.4.2. France

7.4.3. Germany

7.4.4. Others

7.5. APAC

7.5.1. China

7.5.2. Japan

7.5.3. India

7.5.4. Others

7.6. ROW

8. Lateral Epicondylitis Treatment Market Entropy

8.1. New Product Launches

8.2. M&As, Collaborations, JVs and Partnerships

9. Company Profiles

9.1. Chugai Pharmaceutical

9.2. Kasiak Research

9.3. Moecular Phramacology Limited

9.4. Seikagaku Corporation.

9.5. Teikoku Pharma

*More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

10. Appendix

10.1. Abbreviations

10.2. Sources

10.3. Research Methodology

10.4. Bibliography

10.5. Compilation of Expert Insights

10.6. Disclaimer

Company Profile

Select a list of companies from our brochure to be included in the report in addition to the standard list showcased.

Analyst Briefing

Schedule a call with the Research Analyst to understand the report scope in detail and clarify any queries on the market

Data Tables

Get a copy of all the data tables in the report as a separate excel sheet for easy access to data in your presentations

Key Contacts

Select a list of companies from our brochure to get their Key contact persons and use them to reach out directly for B2B discussions

Free Customization

Avail our free analyst hours in order to get additional data apart from the report on your specific areas of interest